This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (4)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • HIV/AIDS  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Ram Yogev, MD

JAMA. 2005;293:2272-2274.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In the late 1980s part of my routine, as the director of a pediatric human immunodeficiency virus (HIV)/AIDS clinic, was to attend funerals of my patients, children who succumbed to this disease. Now I am attending their graduations from high school and some of my patients are going to college. This anecdotal observation about the dramatic impact of highly active antiretroviral treatment (HAART) on the outcome of HIV infection in children is substantiated by the results reported by Berk and colleagues¹ in this issue of JAMA, which demonstrate that decreased HIV progression and improved survival of infected children are associated with early and more advanced antiretroviral therapy (ART).

From the beginning, antiretroviral drugs were not as readily available to children as they were to adults. Some of the reasons included lack of appropriate formulations, poor palatability, limited or no pharmacokinetic data in children, and the smaller . . . [Full Text of this Article]

Author Affiliations: Division of Infectious Diseases, Children’s Memorial Hospital, Chicago, Ill.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Antiretroviral Treatment in Pediatric HIV Infection in the United States: From Clinical Trials to Clinical Practice
Susan Brogly, Paige Williams, George R. Seage, III, James M. Oleske, Russell Van Dyke, Kenneth McIntosh, and for the PACTG 219C Team
JAMA. 2005;293(18):2213-2220.
ABSTRACT | FULL TEXT  

Temporal Trends in Early Clinical Manifestations of Perinatal HIV Infection in a Population-Based Cohort
David R. Berk, Meira S. Falkovitz-Halpern, David W. Hill, Catherine Albin, Antonio Arrieta, Jane M. Bork, Deborah Cohan, Bjorn Nilson, Ann Petru, Juan Ruiz, Peggy Sue Weintrub, Wanda Wenman, Yvonne A. Maldonado, and for the California Pediatric HIV Study Group
JAMA. 2005;293(18):2221-2231.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Firearm Injuries: Epidemic Then, Endemic Now
Christoffel
AJPH 2007;97:626-629.
ABSTRACT | FULL TEXT  

Long-term Experience With Combination Antiretroviral Therapy That Contains Nelfinavir for up to 7 Years in a Pediatric Cohort
Scherpbier et al.
Pediatrics 2006;117:e528-e536.
ABSTRACT | FULL TEXT  

ART for Perinatal HIV Infection Reduces Disease Progression
JWatch Women's Health 2005;2005:10-10.
FULL TEXT  

Early Diagnosis and Treatment of Pediatric HIV Infection Improves Outcomes
AIDS Clin Care 2005;2005:2-2.
FULL TEXT  

Trends in Pediatric HIV Treatment, 1987-2003
AIDS Clin Care 2005;2005:3-3.
FULL TEXT  

Progress in Treatment of Pediatric HIV Infection
JWatch Infect. Diseases 2005;2005:2-2.
FULL TEXT